Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EPI-008
- Development stage
- Preclinical
- Lead developer
- EpiBiotech
- Modality
- Cell Therapies
- Administration
- Intralesional
01
Overview
EPI-008 is an allogeneic cell therapy composed of dermal papilla cells, currently in development by Epibiotech (formerly Stemmore) for the treatment of androgenetic alopecia (AGA). Dermal papilla cells are specialized mesenchymal cells located at the base of hair follicles that play a critical role in hair follicle morphogenesis and the regulation of the hair growth cycle. Unlike autologous therapies that require a patient's own tissue, EPI-008 utilizes an allogeneic approach, potentially offering a standardized, off-the-shelf regenerative treatment. The therapy is administered via local injection into the scalp to stimulate dormant hair follicles and promote hair regrowth. Epibiotech is developing EPI-008 in partnership with GFC Life Science and Beijing Northland Biotech (Nuosi Lande).
- Other names
- Allogeneic Dermal Papilla Cell therapy
Beyond the preview
Go deeper on EPI-008.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EPI-008.